Life Science REIT Future Growth
Future criteria checks 4/6
Life Science REIT is forecast to grow earnings and revenue by 107.7% and 6.3% per annum respectively while EPS is expected to grow by 98.7% per annum.
Key information
107.7%
Earnings growth rate
98.7%
EPS growth rate
| Health Care REITs earnings growth | 0% |
| Revenue growth rate | 6.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 07 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 22 | 32 | 5 | 16 | 3 |
| 12/31/2025 | 18 | 21 | 3 | 14 | 3 |
| 12/31/2024 | 15 | -13 | 1 | 10 | 2 |
| 6/30/2024 | 20 | -40 | -18 | 12 | N/A |
| 3/31/2024 | 20 | -31 | -17 | 10 | N/A |
| 12/31/2023 | 20 | -22 | -16 | 8 | N/A |
| 9/30/2023 | 20 | -25 | -13 | 7 | N/A |
| 6/30/2023 | 19 | -29 | -9 | 7 | N/A |
| 3/31/2023 | 18 | -28 | -9 | 3 | N/A |
| 12/31/2022 | 16 | -28 | -9 | -1 | N/A |
| 12/31/2021 | 1 | 19 | 8 | 8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: JL6 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: JL6 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: JL6 is expected to become profitable in the next 3 years.
Revenue vs Market: JL6's revenue (6.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: JL6's revenue (6.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if JL6's Return on Equity is forecast to be high in 3 years time